ArticleMolecular medicine reports2021
[Corrigendum] miR‑126 overexpression attenuates oxygen‑glucose deprivation/reperfusion injury by inhibiting oxidative stress and inflammatory response via the activation of SIRT1/Nrf2 signaling pathway in human umbilical vein endothelial cells.
Article in Molecular medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the publication of this article, the authors have realized that the two affiliation addresses in the paper were written incorrectly: "The First People's Hospital" and "The Second People's Hospital" should have appeared as "The First People's Hospital of Linhai" and "The Second People's Hospital of Linhai", respectively. Therefore, the author affiliations and addresses in this paper should have appeared as follows: Jixin Li1, Caili Yang1 and Yan Wang2. 1Department of Neurology, The First People's Hospital of Linhai, Taizhou, Zhejiang 317000; 2Department of Neurology, The Second People's Hospital of Linhai, Taizhou, Zhejiang 317016, P.R. China. The authors regret these errors in the presentation of the affiliation addresses, and apologize for any inconvenience caused.[the original article was published in Molecular Medicine Reports 23: Article no. 165, 2021; DOI: 10.3892/mmr.2020.11804].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.